Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.
Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026
Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis.
Journal: American journal of cancer research
Published: May 19, 2025
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant.
Journal: medRxiv : the preprint server for health sciences
Published: March 10, 2025
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.
Journal: Blood advances
Published: January 21, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 03, 2025
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Journal: The New England journal of medicine
Published: June 21, 2023
Hematopoietic stem cell mobilization following PD-1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid.
Journal: European journal of haematology
Published: March 28, 2019
Last Updated: 09/26/2026